Showing results (721-730 of 843) with videos related to

Sort By:
Pageof 85
Plos One|September 26, 2014
Improving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsManjunatha M Venkataswamy, Tony W Ng, Shalu S Kharkwal, et al.
Ebiomedicine|September 11, 2016
Amino Acid Changes in the HIV-1 gp41 Membrane Proximal Region Control Virus Neutralization SensitivityTodd Bradley, Ashley Trama, Nancy Tumba, et al.
Science Translational Medicine|January 8, 2025
An engineered immunogen activates diverse HIV broadly neutralizing antibody precursors and promotes acquisition of improbable mutationsOlivia M Swanson, Qianyi E Zhang, Elizabeth Van Itallie, et al.
Plos One|February 8, 2014
Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infectionSusan Zolla-Pazner, Allan deCamp, Peter B Gilbert, et al.
Journal of Virology|August 17, 2012
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene familyMattia Bonsignori, Justin Pollara, M Anthony Moody, et al.
Journal of Virology|November 29, 2019
Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and PotencyDavid Easterhoff, Justin Pollara, Kan Luo, et al.
Nature Communications|February 21, 2020
Immune checkpoint modulation enhances HIV-1 antibody inductionTodd Bradley, Masayuki Kuraoka, Chen-Hao Yeh, et al.
Journal of Virology|April 10, 2015
Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein BoostSandrine L Hulot, Bette Korber, Elena E Giorgi, et al.
Science Immunology|August 11, 2022
An antibody from single human V<sub>H</sub>-rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusionSai Luo, Jun Zhang, Alex J B Kreutzberger, et al.
Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.
Pageof 85